Navigation Links
Alzheimer's Signs Found in Brains of Young Adults With Gene Mutation
Date:11/6/2012

TUESDAY, Nov. 6 (HealthDay News) -- Scientists have discovered the earliest known evidence of Alzheimer's disease in people with a gene mutation that causes a rare form of the disease that begins at a young age.

The findings from the two studies could improve understanding of how and why Alzheimer's progresses and possibly lead to earlier detection of the disease and improved treatments, according to the researchers.

In one study, researchers conducted brain scans and other tests on 44 young adults, aged 18 to 26, in Colombia. Twenty of them had a mutation of a gene called presenilin 1 (PSEN1) that causes Alzheimer's to develop at an unusually early age, and 24 did not have the mutation. None of the participants showed any signs of mental decline at the time of the study.

There were notable differences in brain structure and function between the young adults with the PSEN1 mutation and those without it. The participants with the PSEN1 mutation had greater activity in regions of the brain called the hippocampus and the parahippocampus, and less gray matter in certain brain areas.

In addition, the cerebrospinal fluid of the young adults with the PSEN1 mutation had higher levels of amyloid beta protein, which is a component of the amyloid plaques in the brain that are associated with Alzheimer's disease.

On average, people with the PSEN1 mutation start to show signs of mental decline at age 45. This study shows that biomarkers in these people are evident at least 20 years before symptoms begin to appear. That's earlier than any previous study has found.

The study was published Nov. 5 in The Lancet Neurology.

"These findings suggest that brain changes begin many years before the clinical onset of Alzheimer's disease, and even before the onset of amyloid plaque deposition. They raise new questions about the earliest brain changes involved in the predisposition to Alzheimer's and the extent to which they could be targeted by future prevention therapies," study leader Dr. Eric Reiman, at the Banner Alzheimer's Institute, in Arizona, said in a journal news release.

In a second study, the same group of researchers found that amyloid plaques begin to accumulate in the brains of people with the PSEN1 mutation when they are in their late 20s.

The findings will "help set the stage for the evaluation of treatments to prevent familial Alzheimer's disease, and hopefully aid our understanding of the early stages of late-onset Alzheimer's disease, which is more widespread," the researchers wrote in the report.

Nick Fox, a professor at the Institute of Neurology at University College London, wrote a journal commentary that accompanied the first study.

"These findings question our models of Alzheimer's disease on several fronts. They suggest that neurodegenerative changes occur over 20 years before symptom onset and somewhat earlier than was suggested by previous brain imaging studies of individuals at risk of inherited Alzheimer's disease," Fox wrote.

"Further research is needed, but one interpretation of these results might be that they add to the accumulating evidence that Alzheimer's disease is characterized by a long presymptomatic period of slowly progressive changes that can potentially be tracked, thereby opening up a therapeutic window for early intervention," he added.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about Alzheimer's disease.

-- Robert Preidt

SOURCE: The Lancet Neurology, news release, Nov. 5, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Simple ovarian cancer symptom survey that checks for 6 warning signs may improve early detection
2. Signs of ADHD Evident by Preschool, Expert Says
3. Bone marrow transplant eliminates signs of HIV infection
4. EP Global Communications, Inc. Achieves Shareholder Approval for Restructuring and Signs Definitive Restructuring Agreement
5. Boys Town Releases 5 Signs of Heat Stroke in Kids
6. Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
7. TeetheMe.com Partners with SwaddleDesigns
8. Obese Teens Can Have Heart Damage Without Showing Signs
9. A place to play: Researcher designs schoolyard for children with autism
10. Even Young Teens Show Signs of Sun Damage
11. Bacteria Found in Other Products From Firm Tied to Meningitis Outbreak: FDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Alzheimer's Signs Found in Brains of  Young Adults With Gene Mutation
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: